Genentech Unclassified
FDA Approved Drugs
Genentech Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 36
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Social Profiles
Company Snapshot
Genentech Unclassified
1 DNA Way, South San Francisco, CA 94080
U.S.A
www.gene.com/ leck@gene.com View on MapFDA Approved Drug Records ( 36 records )
Drug Name
ACTEMRA
Product Number
1
Dosage Form
-
Strength
80MG/4ML
Approval Date
-
Active Ingredient
TOCILIZUMAB
Application Number
125276
Product Number
1
Dosage Form
-
Strength
80MG/4ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ACTEMRA
Product Number
2
Dosage Form
-
Strength
200MG/10ML
Approval Date
-
Active Ingredient
TOCILIZUMAB
Application Number
125276
Product Number
2
Dosage Form
-
Strength
200MG/10ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ACTEMRA
Product Number
3
Dosage Form
-
Strength
400MG/20ML
Approval Date
-
Active Ingredient
TOCILIZUMAB
Application Number
125276
Product Number
3
Dosage Form
-
Strength
400MG/20ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ACTEMRA
Product Number
1
Dosage Form
-
Strength
162MG/0.9ML
Approval Date
-
Active Ingredient
TOCILIZUMAB
Application Number
125472
Product Number
1
Dosage Form
-
Strength
162MG/0.9ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ACTIVASE
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
-
Active Ingredient
ALTEPLASE
Application Number
103172
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ACTIVASE
Product Number
2
Dosage Form
-
Strength
50MG/VIAL
Approval Date
-
Active Ingredient
ALTEPLASE
Application Number
103172
Product Number
2
Dosage Form
-
Strength
50MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
AVASTIN
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
BEVACIZUMAB
Application Number
125085
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
AVASTIN
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
-
Active Ingredient
BEVACIZUMAB
Application Number
125085
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CATHFLO ACTIVASE
Product Number
3
Dosage Form
-
Strength
2MG/VIAL
Approval Date
-
Active Ingredient
ALTEPLASE
Application Number
103172
Product Number
3
Dosage Form
-
Strength
2MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ENSPRYNG
Product Number
1
Dosage Form
-
Strength
120MG/ML
Approval Date
-
Active Ingredient
SATRALIZUMAB
Application Number
761149
Product Number
1
Dosage Form
-
Strength
120MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GAZYVA
Product Number
1
Dosage Form
-
Strength
1000MG/40ML
Approval Date
-
Active Ingredient
OBINUTUZUMAB
Application Number
125486
Product Number
1
Dosage Form
-
Strength
1000MG/40ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HERCEPTIN
Product Number
1
Dosage Form
-
Strength
21MG/ML
Approval Date
-
Active Ingredient
TRASTUZUMAB
Application Number
103792
Product Number
1
Dosage Form
-
Strength
21MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
KADCYLA
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
ADO-TRASTUZUMAB EMTANSINE
Application Number
125427
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
KADCYLA
Product Number
2
Dosage Form
-
Strength
160MG
Approval Date
-
Active Ingredient
ADO-TRASTUZUMAB EMTANSINE
Application Number
125427
Product Number
2
Dosage Form
-
Strength
160MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LUCENTIS
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
-
Active Ingredient
RANIBIZUMAB
Application Number
125156
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LUCENTIS
Product Number
2
Dosage Form
-
Strength
6MG/ML
Approval Date
-
Active Ingredient
RANIBIZUMAB
Application Number
125156
Product Number
2
Dosage Form
-
Strength
6MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN
Product Number
1
Dosage Form
-
Strength
N/A
Approval Date
-
Active Ingredient
SOMATROPIN [rDNA origin]
Application Number
19676
Product Number
1
Dosage Form
-
Strength
N/A
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20168
Product Number
1
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN
Product Number
2
Dosage Form
-
Strength
10MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20168
Product Number
2
Dosage Form
-
Strength
10MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ
Product Number
1
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
1
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ NUSPIN
Product Number
3
Dosage Form
-
Strength
5MG/2ML (2.5MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
3
Dosage Form
-
Strength
5MG/2ML (2.5MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ NUSPIN
Product Number
4
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
4
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ NUSPIN
Product Number
5
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
5
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ PEN
Product Number
2
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
2
Dosage Form
-
Strength
10MG/2ML (5MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NUTROPIN AQ PEN
Product Number
6
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20522
Product Number
6
Dosage Form
-
Strength
20MG/2ML (10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
PERJETA
Product Number
1
Dosage Form
-
Strength
420MG/14ML
Approval Date
-
Active Ingredient
PERTUZUMAB
Application Number
125409
Product Number
1
Dosage Form
-
Strength
420MG/14ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
POLIVY
Product Number
1
Dosage Form
-
Strength
140MG/VIAL
Approval Date
-
Active Ingredient
POLATUZUMAB VEDOTIN-PIIQ
Application Number
761121
Product Number
1
Dosage Form
-
Strength
140MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
POLIVY
Product Number
2
Dosage Form
-
Strength
30MG/VIAL
Approval Date
-
Active Ingredient
POLATUZUMAB VEDOTIN-PIIQ
Application Number
761121
Product Number
2
Dosage Form
-
Strength
30MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
PULMOZYME
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
-
Active Ingredient
DORNASE ALFA
Application Number
103532
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RITUXAN
Product Number
1
Dosage Form
-
Strength
100MG/10ML (10MG/ML)
Approval Date
-
Active Ingredient
RITUXIMAB
Application Number
103705
Product Number
1
Dosage Form
-
Strength
100MG/10ML (10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RITUXAN
Product Number
2
Dosage Form
-
Strength
500MG/50ML (10MG/ML)
Approval Date
-
Active Ingredient
RITUXIMAB
Application Number
103705
Product Number
2
Dosage Form
-
Strength
500MG/50ML (10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
TNKASE
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
-
Active Ingredient
TENECTEPLASE
Application Number
103909
Product Number
1
Dosage Form
-
Strength
50MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
XOLAIR
Product Number
1
Dosage Form
-
Strength
150MG/VIAL
Approval Date
-
Active Ingredient
OMALIZUMAB
Application Number
103976
Product Number
1
Dosage Form
-
Strength
150MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
XOLAIR
Product Number
2
Dosage Form
-
Strength
75MG/0.5ML
Approval Date
-
Active Ingredient
OMALIZUMAB
Application Number
103976
Product Number
2
Dosage Form
-
Strength
75MG/0.5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
XOLAIR
Product Number
3
Dosage Form
-
Strength
150MG/ML
Approval Date
-
Active Ingredient
OMALIZUMAB
Application Number
103976
Product Number
3
Dosage Form
-
Strength
150MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
XOLAIR
Product Number
4
Dosage Form
-
Strength
300MG/2ML
Approval Date
-
Active Ingredient
OMALIZUMAB
Application Number
103976
Product Number
4
Dosage Form
-
Strength
300MG/2ML
Approval Date
-
Regulatory Status
Unclassified
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
37 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
36 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACTEMRA
Application Number
125276
Product Number
1
Active Ingredient
TOCILIZUMAB
Dosage Form
-
Strength
80MG/4ML
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.